ASCLETIS-B: GRANT OF SHARE OPTIONS
Jan 3 04:30 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Dec 30, 2022 04:36 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Jun 30, 2022 05:40 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Mar 31, 2022 05:53 ET
ASCLETIS-B: ANNOUNCEMENT - INSIDE INFORMATION - ASCLETIS EXPANDS RITONAVIR ORAL TABLET PRODUCTION AND ANNOUNCES ORAL DIRECT-ACTING ANTIVIRAL PIPELINE AGAINST SARS-COV-2 VIRUS
Jan 2, 2022 19:00 ET
ASCLETIS-B: EXCHANGE NOTICE - RESUMPTION OF TRADING
Dec 2, 2021 23:40 ET
ASCLETIS-B: ANNOUNCEMENT - INSIDE INFORMATION - INCLUSION IN NEW CATALOGUE OF CHINA NATIONAL REIMBURSEMENT DRUG LIST (NRDL) OF ASCLEVIR/GANOVO REGIMEN, AN ALL-ORAL DIRECT ANTI-HCV THERAPY AND RESUMPTION OF TRADING
Dec 2, 2021 23:00 ET
ASCLETIS-B: TRADING HALT
Dec 2, 2021 21:54 ET
ASCLETIS-B: EXCHANGE NOTICE - TRADING HALT
Dec 2, 2021 20:43 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Sep 30, 2021 07:59 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Jun 30, 2021 06:30 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Apr 7, 2021 07:23 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Mar 31, 2021 06:25 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Dec 31, 2020 03:18 ET
ASCLETIS-B: GRANT OF SHARE OPTIONS
Mar 31, 2020 08:51 ET
ASCLETIS-B: VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY DIRECTORS AND CONTROLLING SHAREHOLDERS
Oct 17, 2019 06:00 ET
ASCLETIS-B: Proposal for Adoption of Share Option Scheme and Notice of Extraordinary General Meeting
May 16, 2019 07:39 ET
No Data
No Data